Expertise in
28
conditions

Dr. Edward J. Holland

Ophthalmology
580 South Loop Road, 
Edgewood, KY 
On Staff At
Accepting New Patients
Expertise in
28
conditions
580 South Loop Road, 
Edgewood, KY 

Overview

Edward Holland is an Ophthalmologist in Edgewood, Kentucky. Dr. Holland is highly rated in 28 conditions, according to our data. His top areas of expertise are Aniridia, Cloudy Cornea, Fuchs Dystrophy, Corneal Transplant, and Cataract Removal. Dr. Holland is currently accepting new patients.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Loyola University Of Chicago Stritch School Of Medicine, 1981

Residency

University Of Minnesota Hospitals, Ophthalmology, 1985

Specialties

Ophthalmology

Licenses

Ophthalmology in OH

Board Certifications

American Board Of Ophthalmology

Fellowships

Uni Of Iowa Hospitals & Clinics, Corneal And External Diseases, 1986

Hospital Affiliations

St Elizabeth Edgewood

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 27 Less Insurance Carriers -

Locations

CEI Physicians, PSC, Inc.
580 South Loop Road, Edgewood, KY 41017
Other Locations
CEI Physicians, PSC, Inc.
1945 Cei Drive, Blue Ash, OH 45242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up
A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Betamethasone Sodium Phosphate
Study Phase: Phase 2
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drugs: Combination of Mycophenolic Acid and Betamethasone Sodium Phosphate, Mycophenolic Acid, Restasis Ophthalmic Emulsion, Xiidra Ophthalmic Solution
Study Phase: Phase 2
Prospective, Open Label, Single Arm, First in Human (FIH) Clinical Study to Assess Safety and Efficacy of the CorNeat Keratoprosthesis for the Treatment of Corneal Blindness
Prospective, Open Label, Single Arm, First in Human (FIH) Clinical Study to Assess Safety and Efficacy of the CorNeat Keratoprosthesis for the Treatment of Corneal Blindness
Enrollment Status: Terminated
Publish Date: September 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Device
Study Phase: Phase 1/Phase 2
A Phase 2 Open Label Trial of ST266 Eye Drops in the Treatment of Persistent Corneal Epithelial Defects
A Phase 2 Open Label Trial of ST266 Eye Drops in the Treatment of Persistent Corneal Epithelial Defects
Enrollment Status: Completed
Publish Date: August 18, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery
A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery
Enrollment Status: Completed
Publish Date: June 29, 2017
View 6 Less Clinical Trials

120 Total Publications

Internal validation of a convolutional neural network pipeline for assessing meibomian gland structure from meibography.
Internal validation of a convolutional neural network pipeline for assessing meibomian gland structure from meibography.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: January 10, 2025
Similar Doctors
Christopher D. Riemann
Expertise in
29
conditions
Dr. Christopher D. Riemann
Ophthalmology
Expertise in
29
conditions
Dr. Christopher D. Riemann
Ophthalmology

Cincinnati Eye Institute

1945 Cei Drive, 
Blue Ash, OH 
 (18.5 miles away)
513-984-5133
Experience:
32+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Riemann is an Ophthalmologist in Blue Ash, Ohio. Dr. Riemann has been practicing medicine for over 32 years is highly rated in 29 conditions, according to our data. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Riemann is currently accepting new patients.

Expertise in
14
conditions
Dr. Arjun Sood
Ophthalmology
Expertise in
14
conditions
Dr. Arjun Sood
Ophthalmology

Cei Physicians PSC LLC

580 S Loop Rd Ste 200, 
Edgewood, KY 
 (0.1 miles away)
513-984-5133
Languages Spoken:
English
See accepted insurances

Arjun Sood is an Ophthalmologist in Edgewood, Kentucky. Dr. Sood is highly rated in 14 conditions, according to our data. His top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Neuroretinitis, Punctate Inner Choroidopathy, and Vitrectomy.

Expertise in
13
conditions
Dr. Jeffrey Nerad
Ophthalmology
Expertise in
13
conditions
Dr. Jeffrey Nerad
Ophthalmology

Northmark Pharmacy

1945 Cei Dr, 
Blue Ash, OH 
 (18.5 miles away)
513-984-5133
Languages Spoken:
English
See accepted insurances

Jeffrey Nerad is an Ophthalmologist in Blue Ash, Ohio. Dr. Nerad is highly rated in 13 conditions, according to our data. His top areas of expertise are Eyelid Drooping, Ptosis, Entropion, and Chalazion.

Frequently Asked Questions about Dr. Edward J. Holland

How do I make an appointment with Dr. Edward J. Holland?

You can book an appointment with Dr. Edward J. Holland by calling their office at 513-984-5133. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Edward J. Holland a top-rated expert for Aniridia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward J. Holland is classified as an Elite expert for Aniridia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Edward J. Holland specialize in?

While Dr. Edward J. Holland is a Ophthalmology, they have specific expertise in Aniridia, Cloudy Cornea, and Fuchs Dystrophy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Edward J. Holland participate in research or clinical trials?

Yes. Dr. Edward J. Holland has published 120 articles and abstracts on conditions like Aniridia. You can view a list of Dr. Edward J. Holland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Edward J. Holland accept my insurance?

Dr. Edward J. Holland accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 513-984-5133 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Holland's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 17 Advanced Conditions
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile